The mice were injected intratumorally with PBS, CaP-OMVs@P2O-Ads plus CD8+ T cells antibody, and CaP-OMVs@P2O-Ads when the tumor reached 100–150 mm3. The gene discussed is CD8A; the disease is neoplasm.